Equities research analysts expect Dolby Laboratories, Inc. (NYSE:DLB) to post sales of $297.15 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Dolby Laboratories’ earnings. The highest sales estimate is $300.11 million and the lowest is $294.96 million. Dolby Laboratories posted sales of $351.82 million during the same quarter last year, which would indicate a negative year-over-year growth rate of 15.5%. The firm is scheduled to announce its next earnings report after the market closes on Tuesday, May 4th.

On average, analysts expect that Dolby Laboratories will report full year sales of $1.26 billion for the current year, with estimates ranging from $1.25 billion to $1.28 billion. For the next financial year, analysts anticipate that the business will report sales of $1.34 billion, with estimates ranging from $1.32 billion to $1.36 billion. Zacks Investment Research’s sales averages are an average based on a survey of research firms that cover Dolby Laboratories.

Several analysts recently issued reports on DLB shares. B. Riley upped their price objective on shares of Dolby Laboratories from $79.00 to $89.00 and gave the company a “neutral” rating in a research note on Friday, January 29th. Zacks Investment Research upgraded Dolby Laboratories from a “sell” rating to a “hold” rating and set a $98.00 price target for the company in a research report on Tuesday, February 23rd. Barrington Research cut Dolby Laboratories from an “outperform” rating to a “market perform” rating in a report on Tuesday, January 26th. Finally, Tigress Financial restated a “buy” rating on shares of Dolby Laboratories in a report on Thursday, February 25th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $83.75.

In other Dolby Laboratories news, VP Ryan Nicholson sold 2,237 shares of the stock in a transaction dated Wednesday, February 3rd. The shares were sold at an average price of $91.01, for a total transaction of $203,589.37. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Mark Andrew Sherman sold 27,663 shares of Dolby Laboratories stock in a transaction dated Friday, February 5th. The shares were sold at an average price of $91.60, for a total transaction of $2,533,930.80. The disclosure for this sale can be found here. In the last ninety days, insiders sold 108,640 shares of company stock worth $10,287,333. Corporate insiders own 37.30% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the business. BlackRock Inc. boosted its position in shares of Dolby Laboratories by 9.7% during the fourth quarter. BlackRock Inc. now owns 3,687,383 shares of the electronics maker’s stock worth $358,155,000 after buying an additional 326,910 shares during the period. Jackson Square Partners LLC purchased a new position in shares of Dolby Laboratories in the fourth quarter valued at approximately $210,338,000. Victory Capital Management Inc. grew its holdings in shares of Dolby Laboratories by 658.7% in the fourth quarter. Victory Capital Management Inc. now owns 706,047 shares of the electronics maker’s stock valued at $68,579,000 after purchasing an additional 612,992 shares in the last quarter. Norges Bank purchased a new stake in Dolby Laboratories during the 4th quarter worth approximately $67,801,000. Finally, Fiera Capital Corp lifted its holdings in Dolby Laboratories by 10.3% during the 4th quarter. Fiera Capital Corp now owns 685,993 shares of the electronics maker’s stock worth $66,630,000 after buying an additional 63,820 shares in the last quarter. 58.58% of the stock is currently owned by institutional investors.

DLB stock traded down $0.04 during trading on Friday, hitting $103.37. The stock had a trading volume of 12,883 shares, compared to its average volume of 500,289. The stock has a market capitalization of $10.50 billion, a P/E ratio of 45.96, a PEG ratio of 3.27 and a beta of 0.89. The company’s 50-day moving average price is $100.39 and its two-hundred day moving average price is $92.69. Dolby Laboratories has a twelve month low of $52.13 and a twelve month high of $104.74.

Dolby Laboratories Company Profile

Dolby Laboratoties, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast, and entertainment industries. Its products include Cinema Imaging, Cinema Audio, Dolby Conference Phone, Dolby Voice Room, and Other Products. The company was founded by Ray Milton Dolby in 1965 and is headquartered in San Francisco, CA.

See Also: What Is an EV Stock?

Get a free copy of the Zacks research report on Dolby Laboratories (DLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.